J. Kyle Anderson, MD

Associate Professor, Department of Urology

J. Kyle Anderson

Contact Info


Administrative Assistant Name
Resha Tejpaul

Administrative Phone

Administrative Fax Number

Additional Locations


Associate Professor, Department of Urology

Program Director, Urology Residency, Department of Urology


University of Minnesota Medical School, Minneapolis, MN

University of Minnesota, Minneapolis, MN (Urology)

University of Texas Southwestern Medical School, Dallas, TX (Endourology and Laparoscopy)


Dr. Kyle Anderson is interested in a variety of urologic conditions, including laparoscopic treatment of abnormalities including kidney cancer, ureteral pelvic junction obstruction, prostate cancer, adrenal abnormalities. He also specializes in minimally invasive thermotherapy for kidney cancer and kidney stone disease.

When he’s not in clinic, Anderson is an associate professor of urologic surgery at the University of Minnesota Medical School. His research focuses on the use of thermotherapy (cryotherapy and radiofrequency ablation) for the treatment of kidney cancer.


  • Hematuria (blood in urine)
  • Kidney stones
  • Polycystic kidney disease
  • Kidney cancer
  • Prostate cancer
  • Ureteral cancer
  • Ureteral pelvic junction obstruction
  • Ureteral obstruction

Awards & Recognition

  • Minnesota Monthly "Best Doctors" (2014)
  • Mpls.St.Paul Magazine "Top Doctor" (2015)



  • Sathianathen NJ, Krishna S, Anderson JK, Weight CJ, Gupta S, Konety BR, Griffith TS. The current status of immunobased therapies for metastatic renal-cell carcinoma. Immunotargets Ther. 2017 Dec.
  • Mandalapu RS, Remzi M, de Reijke TM, Margulis V, Palou J, Kapoor A, Yossepowitch O, Coleman J, Traxer O, Anderson JK, Catto J, de la Rosette J, O'Brien T, Zlotta A, Matin SF. Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma. World J Urol. 2017 Mar.
  • Zabell JR, Larson G, Koffel J, Li D, Anderson JK, Weight CJ. Use of the Modification of Diet in Renal Disease Equation for Estimating Glomerular Filtration Rate in the Urologic Literature. J Endourol. 2016 Aug.
  • McAdams S, Sweet RM, Anderson JK. Operating Endoscopically with “Two Hands” to Remove Calcified Permanent Suture After Pyeloplasty. J Endourol Case Rep. 2016 Jan.
  • Rostambeigi N, Goldfarb R, Hunter DW, Anderson JK. Fibromuscular Dysplasia in a Normotensive Patient Presented with Renal Infarct: Case Report and Endovascular Technique. Vasc Endovascular Surg. 2015 Oct.
  • Kumar N, Crocker T, Smith T, Pow-Sang J, Spiess PE, Egan K, Quinn G, Schell M, Sebti S, Kazi A, Chuang T, Salup R, Helal M, Zagaja G, Trabulsi E, McLarty J, Fazili T, Williams CR, Schreiber F, Slaton J, Anderson JK. Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate cancer. Contemp Clin Trials. 2012 Mar.
  • Lucas SM, Sundaram CP, Wolf JS Jr, Leveillee RJ, Bird VG, Aziz M, Pautler SE, Luke P, Erdeljan P, Baldwin DD, Ebrahimi K, Nadler RB, Rebuck D, Thomas R, Lee BR, Boylu U, Figenshau RS, Munver R, Averch TD, Gayed B, Shalhav AL, Gundeti MS, Castle EP, Anderson JK, Duffey BG, Landman J, Okhunov Z, Wong C, Strom KH. Factors that impact the outcome of minimally invasive pyeloplasty: results of the Multi-institutional Laparoscopic and Robotic Pyeloplasty Collaborative Group. J Urol. 2012 Feb.
  • Duffey B, Nguyen V, Lund E, Koopmeiners JS, Hulbert J, Anderson JK. Intermediate-term outcomes after renal cryoablation: results of a multi-institutional study. J Endourol. 2012 Jan.
  • Anderson JK, Alanee S, Lindgren B, Slaton J. The risk of bladder cancer in patients diagnosed with other primary neoplasms: Analysis of the SEER database. Urol Oncol. 2011 Jul 22.
  • O. Ortiz-Alvarado, R. Miyaoka, C. Kriedberg, A. Moeding, M. Stessman, JK Anderson, M. Monga: Impact of dietary counseling on urinary stone risk parameters in recurrent stone formers. J Endourol. 2011 Mar 1. 


Board Certifications

American Board of Urology